BioCentury
ARTICLE | Company News

Cylex, ViraCor-IBT deal

February 18, 2013 8:00 AM UTC

ViraCor-IBT will purchase the assets of Cylex, which develops and commercializes in vitro diagnostics for transplant immunity. The acquisition includes ImmuKnow, an immune cell function assay that mea...